High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.
Xibao YuCunte ChenYanyun HuKehan LiYi-Kai ZhangZheng ChenDingrui NieRili GaoYouxue HuangMengjun ZhongCaixia WangShunqing WangYixin ZengYangqiu LiChengwu ZengPublished in: Cancer medicine (2023)
High expression of LOC541471, GDAP1, SOD1, and STK25 may be biomarkers for risk stratification of AML patients, which may provide novel insight into evaluating prognosis, monitoring progression, and designing combinational targeted therapies.